Big pharmaceutical companies are poised to accelerate partnerships and licensing deals as they attempt to bolster falling innovation, according to a survey of industry trends.

More than half of companies anticipate a stronger focus on collaborations with other companies over the next five years and see business development as the most important way to boost productivity.